|
| | Publication Year | Title | Author(s) |
| 81 | Mar-2021 | Prognostic indices in diffuse large B-cell lymphoma in the rituximab era: an analysis of the UK National Cancer Research Institute R-CHOP 14 versus 21 phase 3 trial. | Gleeson, Mary; Counsell, Nicholas; Cunningham, David; Lawrie, Anthony; Clifton-Hadley, Laura; Hawkes, Eliza A ; McMillan, Andrew; Ardeshna, Kirit M; Burton, Cathy; Chadwick, Nick; Gambell, Joanna; Smith, Paul; Mouncey, Paul; Pocock, Christopher; Radford, John; Davies, John; Turner, Deborah; Kruger, Anton; Johnson, Peter; Linch, David |
| 82 | 22-Feb-2021 | Rapid resistance of FGFR-driven gastric cancers to regorafenib and targeted FGFR inhibitors can be overcome by parallel inhibition of MEK. | Lau, David K ; Luk, Ian Y; Jenkins, Laura J; Martin, Andrew; Williams, David S ; Schoffer, Kael L; Chionh, Fiona; Buchert, Michael; Sjoquist, Katrin; Boussioutas, Alex; Hayes, Sarah A; Ernst, Matthias ; Weickhardt, Andrew J ; Pavlakis, Nick; Tebbutt, Niall C ; Mariadason, John M |
| 83 | 20-Feb-2021 | Prognostic performance of qSOFA in oncology patients admitted to the emergency department with suspected infection. | Koh, Tze Lui ; Canet, Emmanuel; Amjad, Sobia; Bellomo, Rinaldo ; Taylor, David McD ; Gan, Hui K ; Marhoon, Nada ; Lim, Andrew Boon Ming ; Ong, Wee Loon ; Krishnan, Vivek; Khor, Richard |
| 84 | 15-Feb-2021 | Prognostic Significance of Post-Surgery Circulating Tumor DNA in Non-Metastatic Colorectal Cancer: Individual Patient Pooled Analysis of Three Cohort Studies. | Tie, Jeanne; Cohen, Joshua D; Lo, Serigne N; Wang, Yuxuan; Li, Lu; Christie, Michael; Lee, Margaret; Wong, Rachel; Kosmider, Suzanne; Skinner, Iain; Wong, Hui Li; Lee, Belinda; Burge, Matthew E; Yip, Desmond; Karapetis, Christos S; Price, Timothy J; Tebbutt, Niall C ; Haydon, Andrew M; Ptak, Janine; Schaeffer, Mary J; Silliman, Natalie; Dobbyn, Lisa; Popoli, Maria; Tomasetti, Cristian; Papadopoulos, Nickolas; Kinzler, Kenneth W; Vogelstein, Bert; Gibbs, Peter |
| 85 | Feb-2021 | Use of Ultrasonography Facilitates Noninvasive Evaluation of Lymphadenopathy in a Lymph Node Diagnostic Clinic. | Loh, Zoe ; Hawkes, Eliza A ; Chionh, Fiona; Azad, Arun; Chong, Geoffrey |
| 86 | Feb-2021 | Pilot Study of Patients' Preferences for Immediate Resection Versus a Watch and Wait Approach After Neoadjuvant Chemoradiation for Locally Advanced Rectal Cancer. | Gunjur, Ashray ; Chazan, Grace; Newnham, Genni; McLachlan, Sue-Anne |
| 87 | 29-Jan-2021 | Dual anti-angiogenesis agents bevacizumab plus trebananib, without chemotherapy, in first-line treatment of metastatic colorectal cancer: results of a phase II study. | Mooi, Jennifer K ; Chionh, Fiona; Savas, Peter; Da Gama Duarte, Jessica; Chong, Geoffrey ; Brown, Stephen; Wong, Rachel; Price, Timothy; Wann, Alysson ; Skrinos, Effie; Mariadason, John M ; Tebbutt, Niall C |
| 88 | 1-Jan-2021 | Transcatheter aortic valve replacement in patients with a history of cancer: Periprocedural and long-term outcomes. | Murphy, Alexandra C ; Koshy, Anoop N ; Cameron, William; Horrigan, Mark ; Kearney, Leighton; Yeo, Belinda ; Farouque, Omar ; Yudi, Matias B |
| 89 | Jan-2021 | Inefficiencies in phase II to phase III transition impeding successful drug development in glioblastoma. | Balasubramanian, Adithya ; Gunjur, Ashray ; Hafeez, Umbreen ; Menon, Siddharth; Cher, Lawrence M ; Parakh, Sagun ; Gan, Hui K |
| 90 | 2021 | Immune Checkpoint Inhibition With Chemoradiotherapy in Stage III Non-small-cell Lung Cancer: A Systematic Review and Meta-analysis of Safety Results. | Balasubramanian, Adithya ; Onggo, James; Gunjur, Ashray ; John, Thomas ; Parakh, Sagun |
| 91 | 2021 | Personalizing First-Line Systemic Therapy in Metastatic Colorectal Cancer: Is There a Role for Initial Low-Intensity Therapy in 2021 and Beyond? A Perspective From Members of the Australasian Gastrointestinal Trials Group. | Dunn, Catherine; Hong, Wei; Gibbs, Peter; Ackland, Stephen; Sjoquist, Katrin; Tebbutt, Niall C ; Price, Timothy; Burge, Matthew |
| 92 | 2021 | Relevance of sun safety in patients commencing crizotinib for non-small cell lung cancer. | Heynemann, Sarah; Mitchell, Paul |
| 93 | Dec-2020 | New insights into ErbB3 function and therapeutic targeting in cancer. | Hafeez, Umbreen ; Parslow, Adam C; Gan, Hui K ; Scott, Andrew M |
| 94 | Dec-2020 | Analysis of angiogenic and stromal biomarkers in a large malignant mesothelioma cohort. | Chia, Puey Ling ; Russell, Prudence; Asadi, Khashi; Thapa, Bibhusal ; Gebski, Val; Murone, Carmel ; Walkiewicz, Marzena; Eriksson, Ulf; Scott, Andrew M ; John, Thomas |
| 95 | Dec-2020 | Clinical and radiological evolution of cerebral amyloid angiopathy-related inflammation in the context of anti-PD-1 immunotherapy. | Lasocki, Arian; Kee, Damien |
| 96 | Dec-2020 | Real-world impact of anti-HER2 therapy-related cardiotoxicity in patients with advanced HER2-positive breast cancer. | Conduit, C; de Boer, R H; Lok, S; Gibbs, P; Malik, L; Loh, Zoe ; Yeo, Belinda ; Greenberg, S; Devitt, B; Lombard, J; Nottage, M; Collins, I; Torres, J; Nolan, M; Nott, L |
| 97 | 26-Nov-2020 | The role of BCL-2 family proteins and therapeutic potential of BH3-mimetics in malignant pleural mesothelioma. | Arulananda, Surein; Lee, Erinna F; Fairlie, W Douglas; John, Thomas |
| 98 | 1-Nov-2020 | Threshold Change in CEA as a Predictor of Non-Progression to First-Line Systemic Therapy in Metastatic Colorectal Cancer Patients With Elevated CEA. | Gulhati, Pat; Yin, Jun; Pederson, Levi; Schmoll, Hans-Joachim; Hoff, Paulo; Douillard, Jean-Yves; Hecht, J Randolph; Tournigand, Christophe; Tebbutt, Niall C ; Chibaudel, Benoist; Gramont, Aimery De; Shi, Qian; Overman, Michael James |
| 99 | Nov-2020 | Osimertinib versus platinum-pemetrexed for patients with EGFR T790M advanced NSCLC and progression on a prior EGFR-tyrosine kinase inhibitor: AURA3 overall survival analysis. | Papadimitrakopoulou, V A; Mok, T S; Han, J-Y; Ahn, M-J; Delmonte, A; Ramalingam, S S; Kim, S W; Shepherd, F A; Laskin, J; He, Y; Akamatsu, H; Theelen, W S M E; Su, W-C; John, Thomas ; Sebastian, M; Mann, H; Miranda, M; Laus, G; Rukazenkov, Y; Wu, Y-L |
| 100 | Nov-2020 | Routine Blood Tests in Asymptomatic Patients With Indolent Lymphoma Have Limited Ability to Detect Clinically Significant Disease Progression. | Piercey, Oliver A; Loh, Zoe ; Chan, Joanna; Chong, Geoffrey ; Grigg, Andrew P ; Cheema, Steven ; Gill, Gurjot; Whybird, Matthew; Cushion, Tania; Hawkes, Eliza A |
